Skip to content
Screener

Reported April 23, 2026 · Before market open

Revenue$844.9MBeat by $64.6M
EPS$2.13Beat by $0.45
Revenue estimate$780.3M
EPS estimate$1.68

Next report

Oct 22, 2026 (in 2 months)
Revenue estimate$825.9M
EPS estimate$2.18

Financials

Q1 2026

Income statement

See full
Revenue$844.9M+21.0%
Gross profit$296.4M+27.8%
Operating income$177.1M+65.5%
Net income$138.8M+54.6%
EPS (diluted)$1.92+56.1%

Balance sheet

See full
Cash & equivalents$521.4M+29.0%
Total debt$321.0M+4.4%
Total equity$3.0B+11.5%
Total assets$4.1B+13.6%

Cash flow

See full
Operating cash flow$89.9M-30.5%
CapEx$42.7M-40.1%
Free cash flow$47.2M-18.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$18.07B+11.6%
Enterprise value$17.87B+11.1%
P/E33.3×-1.4×
P/S5.6×0.0×

Profitability

See full
Gross margin36.3%+1.7pp
Operating margin20.3%+1.2pp
Net margin16.8%+0.7pp
FCF margin14.2%+3.6pp

Returns & leverage

See full
Return on equity19.1%+1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.1×

Segments

By segment

See full
Proprietary Products$694.3M+23.3%
West Vantage$150.6M

FAQ

When did West Pharmaceutical Services report Q1 2026 earnings?
West Pharmaceutical Services (WST) reported Q1 2026 earnings on April 23, 2026 before market open.
What were West Pharmaceutical Services's Q1 2026 revenue and EPS?
West Pharmaceutical Services reported revenue of $844.9M and eps of $2.13 for Q1 2026.
Did West Pharmaceutical Services beat estimates in Q1 2026?
Revenue beat the consensus estimate of $780.3M by $64.6M. EPS beat the consensus estimate of $1.68 by $0.45.
How did West Pharmaceutical Services's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.0% from $698.0M a year earlier and eps grew 46.9% from $1.45.
Where can I find West Pharmaceutical Services's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000105770-26-000047) and the 10-Q periodic report (0000105770-26-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.